Dev Prasad
Stock Analyst at LUCID CAPITAL MARKETS
(0.65)
# 3,909
Out of 4,944 analysts
4
Total ratings
50%
Success rate
-16.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dev Prasad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Initiates: Buy | $5 | $1.10 | +354.55% | 1 | Jun 17, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $24 | $9.08 | +164.46% | 1 | Dec 17, 2024 | |
| IBIO iBio, Inc. | Initiates: Buy | $6 | $0.73 | +723.05% | 1 | Dec 17, 2024 | |
| CALC CalciMedica | Initiates: Buy | $13 | $2.35 | +453.19% | 1 | Dec 17, 2024 |
Opus Genetics
Jun 17, 2025
Initiates: Buy
Price Target: $5
Current: $1.10
Upside: +354.55%
Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $9.08
Upside: +164.46%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $0.73
Upside: +723.05%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.35
Upside: +453.19%